Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Prostatic Neoplasms 9Pancreatic Neoplasms 2Breast Neoplasms 2Vitamin D Deficiency 1Thyroid Nodule 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Obesity 1Leukemia 1Hypocalcemia 1Cholangiocarcinoma 1Castration-resistant Prostate Cancer 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1

Interventions

Trastuzumab 303Paclitaxel 256Cyclophosphamide 251Docetaxel 238Capecitabine 175Letrozole 163Carboplatin 163Doxorubicin 145Fulvestrant 144Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 88Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 44Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × Calcitriol × Clear all
NCT01293682 2022-04-20

Effects of High Dose Calcitriol in Breast Cancer Patients

University of Rochester

Phase 2 Completed
12 enrolled 12 charts
Breast

Breast Neoplasms

NCT00904033 2019-04-23

Calcitriol, Physical Activity, and Bone Health in Cancer Survivors

University of Rochester

Phase 2 Completed
41 enrolled 27 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡